Dr. Tatiana Zhelninova-Bosch, MD, PhD, is International Medical Director of the VAANAA / MEDEZE Group (Bangkok), one of Asia's largest biotechnology ecosystems integrating biobanking, GMP laboratories, cell therapeutics, and longevity medicine. A cardiologist by training with an MBA in healthcare management, she brings more than 30 years of clinical practice and over a decade as principal investigator and national coordinator of clinical trials (phases IIA–IV). She is a member of the European Society of Cardiology and of the American Academy & Association of Regenerative Medicine, and has launched hospitals, research centers, and clinical-trial units across Europe, the Middle East, and Asia.